Yao Jun, Director of the Planning Department of the Ministry of Industry and Information Technology, stated that in 2024, we achieved a complete "zeroing" of foreign investment access restrictions in the manufacturing sector, which should be regarded as an important landmark achievement in our promotion of high-level opening up. In 2024, the actual foreign investment utilized in the manufacturing industry exceeded 220 billion yuan, with the proportion of actual foreign investment utilized in high-tech manufacturing reaching 11.7%. Among them, the medical device and instrument manufacturing industry and the computer and office equipment manufacturing industry showed outstanding growth, with actual foreign investment utilized increasing by 98.7% and 21.9%, respectively. A number of foreign investment projects, including AstraZeneca's new small molecule drug factory project, the Laisail fiber project of Singapore's Golden Eagle Group, and Sanofi's insulin production base project, have been signed and implemented